5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2012 by Seoul St. Mary's Hospital
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Yoo-Jin Kim, Seoul St. Mary's Hospital
ClinicalTrials.gov Identifier:
NCT01652781
First received: July 11, 2012
Last updated: July 25, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)